Gold Sponsor
AstraZeneca
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
Loxo@Lilly
Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating oncology medicines that unequivocally show early signs of clinical activity and will matter to patients.
Novartis AG
Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
- www.roche.com
- Booth No. 1
Silver Sponsor
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.
BeiGene Switzerland GmbH
BeiGene is a global biotechnology company that is discovering and developing innovative oncology treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them.
- www.beigene.com
- Booth No. 2
Gilead Sciences, Inc
Gilead and Kite Oncology are creating the future of oncology. From antibody-drug conjugates and small molecules to cell therapy-based approaches, our R&D programs and partnerships are creating possibilities for people with overlooked, underserved and difficult-to-treat cancers. We are focused on helping to bring more life to people with cancer and changing the way cancer is treated.
Sanofi
At Sanofi, we recognize the burden that cancer places on patients and caregivers. Our aspiration is to drive the evolution of the treatment of cancer, transform patient care, and impact the lives of people living with many different types of cancer.
Seagen
Seagen is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. We are leveraging our expertise in antibodies to build a portfolio of proprietary antibody-drug conjugates and immuno-oncology agents in clinical trials for hematologic malignancies and solid tumors.
- www.seagen.com
- Booth No.3
Supporters
Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit our website and follow us on Twitter.
preclinics Italia
preclinics Italia presents beacies. Our team specializes in the design, selection and production of recombinant antibodies, especially the variable domains of camelid VHH antibodies (also known as Nanobodies®) and their functionalized derivatives. Our strength and specialty lie in producing customized VHH ligands for various research and biomedical diagnostic applications. Visit our website to configure your customized antibody.
Servier
Servier is a global pharmaceutical group governed by a Foundation, with a strong international presence in 150 countries. Servier aims to become a focused and innovative player in oncology as the Group has placed it among its priorities, allocating over 50% of R&D investment to this field, balanced between monoclonal antibodies and targeted small molecules.
Exhibitors
MedChemExpress
MedChemExpress supports scientists around the world in their research by offering a wide range of high-quality research chemicals
and biochemicals, including inhibitors, agonists, screening libraries, recombinant proteins, dye reagents, peptides and kits. We take pride in being a competent and trustworthy partner, offering only the highest-grade products and services at competitive prices!
- www.medchemexpress.com
- Booth No. 7
Resilience
Resilience offers a Remote Patient Care solution dedicated to cancer patients and caregivers. Through a mobile application and a Remote Patient Monitoring platform, Resilience ensure better care. The mobile app helps individuals to manage treatment-related side effects while its RPM platform, a Class IIa medical device, allows healthcare professionals to better understand their patients and to improve their care.
- www.resilience.care
- Booth No. 4
Educational Grants
Janssen
At Janssen, we’re creating a future where disease is a thing of the past. We’re working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. Our focus areas of medicine: Oncology, Immunology, Neuroscience, Cardiovascular Medicine & Pulmonary Hypertension, Retina, and Infectious Diseases & Vaccines.
MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.